Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06511570
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-08
Brief Title:
A Study Comparing the Safety Tolerability and Pharmacokinetics of Sabirnetug IV and Sabirnetug rHuPH20 SC in Healthy Participants
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Open-Label Study Comparing the Safety Tolerability and Pharmacokinetics of Single-Dose Intravenous Sabirnetug ACU193 and Multiple-Dose Subcutaneous Sabirnetug ACU193 rHuPH20 in Healthy Participants
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Study Comparing the Safety Tolerability and Pharmacokinetics of Sabirnetug IV and Sabirnetug rHuPH20 SC in Healthy Participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None